REV3L is the DNA polymerase subunit of pol 6, an enzyme involved in tolerance of genomic damage. REV3L is essential for embryonic development, for reasons that remain to be clarified. We find that Rev3L-defective mammalian cells have high rates of spontaneous chromosome instability, a feature that is also characteristic of many cancers. The PI's laboratory has developed a conditional pol zeta-null mouse, and it appears that a subset of tumors in such mice are preferentially Rev3L-null. Pol 6 may thus be an example of a specialized DNA polymerase that acts as a tumor suppressor gene. The proposed experiments will use a new combination of cellular, genetic, and mouse model approaches to test the extent to which REV3L protects cells against endogenous DNA-damaging stress and chromosomal instability, and to investigate the process of tumor development in the absence of REV3L.
The aims are (1) to test the hypothesis that REV3L enables cells to tolerate DNA damage that can disrupt chromosome integrity and interfere with cell proliferation;(2) to determine which domains of the REV3L protein are necessary for normal cell proliferation and genome stability;(3) to test whether loss of REV3L function in mice promotes tumor development.

Public Health Relevance

DNA damaging agents produce mutations that affect human health, aging, and genome instability. Our research suggests that the human DNA repair protein REV3L suppresses tumor formation by helping to prevent genome instability. Knowledge of the REV3L status of tumors could be useful in tailoring therapies, and specific interference with REV3L function could be expected to influence tumor development.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Tomida, Junya; Takata, Kei-Ichi; Bhetawal, Sarita et al. (2018) FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells. EMBO J 37:
Schibler, Andria; Koutelou, Evangelia; Tomida, Junya et al. (2016) Histone H3K4 methylation regulates deactivation of the spindle assembly checkpoint through direct binding of Mad2. Genes Dev 30:1187-97
Lin, Ying-Chih; Owen, Nichole; Minko, Irina G et al. (2016) DNA polymerase ? limits chromosomal damage and promotes cell survival following aflatoxin exposure. Proc Natl Acad Sci U S A 113:13774-13779
Lange, Sabine S; Tomida, Junya; Boulware, Karen S et al. (2016) The Polymerase Activity of Mammalian DNA Pol ? Is Specifically Required for Cell and Embryonic Viability. PLoS Genet 12:e1005759
Manandhar, Mandira; Boulware, Karen S; Wood, Richard D (2015) The ERCC1 and ERCC4 (XPF) genes and gene products. Gene 569:153-61
Perez, Carlos J; Mecklenburg, Lars; Jaubert, Jean et al. (2015) Increased Susceptibility to Skin Carcinogenesis Associated with a Spontaneous Mouse Mutation in the Palmitoyl Transferase Zdhhc13 Gene. J Invest Dermatol 135:3133-3143
Tomida, Junya; Takata, Kei-ichi; Lange, Sabine S et al. (2015) REV7 is essential for DNA damage tolerance via two REV3L binding sites in mammalian DNA polymerase ?. Nucleic Acids Res 43:1000-11
Wood, Richard D; Lange, Sabine S (2014) Breakthrough for a DNA break-preventer. Proc Natl Acad Sci U S A 111:2864-5
Wood, Richard D (2013) DNA damage tolerance and a web of connections with DNA repair at Yale. Yale J Biol Med 86:507-16
Lange, Sabine S; Bedford, Ella; Reh, Shelley et al. (2013) Dual role for mammalian DNA polymerase ? in maintaining genome stability and proliferative responses. Proc Natl Acad Sci U S A 110:E687-96

Showing the most recent 10 out of 13 publications